Max Bulsara

19.6k total citations · 1 hit paper
359 papers, 12.1k citations indexed

About

Max Bulsara is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Max Bulsara has authored 359 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 57 papers in Public Health, Environmental and Occupational Health and 55 papers in Surgery. Recurrent topics in Max Bulsara's work include Breast Cancer Treatment Studies (37 papers), Global Cancer Incidence and Screening (24 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Max Bulsara is often cited by papers focused on Breast Cancer Treatment Studies (37 papers), Global Cancer Incidence and Screening (24 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Max Bulsara collaborates with scholars based in Australia, United Kingdom and United States. Max Bulsara's co-authors include Billie Giles‐Corti, Gavin R. McCormack, Lisa Wood, Terri Pikora, Minghao Zheng, Jane Fitzpatrick, Anna Timperio, Enrico Rossi, Leon A. Adams and Timothy W. Jones and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Max Bulsara

353 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials

2016 234 citations Max Bulsara et al. profile →

Peers

Countries citing papers authored by Max Bulsara

Since Specialization

Citations

This map shows the geographic impact of Max Bulsara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Bulsara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Bulsara more than expected).

Fields of papers citing papers by Max Bulsara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Bulsara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Bulsara. The network helps show where Max Bulsara may publish in the future.

Co-authorship network of co-authors of Max Bulsara

This figure shows the co-authorship network connecting the top 25 collaborators of Max Bulsara. A scholar is included among the top collaborators of Max Bulsara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Bulsara. Max Bulsara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational study 2025 ·The Medical Journal of Australia ·M. Luke Marinovich, Nehmat Houssami, Andrew J. Spillane, G. Bruce Mann, Donna Taylor, (unknown), (unknown), Max Bulsara, Patsy S. Soon, (unknown), Christobel Saunders	0
2	Early ambulation following lower limb burn and surgery is associated with improved long-term functional outcome and reduced hospital length of stay: A longitudinal cohort study 2025 ·Burns ·(unknown), Dana Hince, (unknown), Piers Truter, (unknown), Fiona Wood, Max Bulsara, (unknown), (unknown), Dale W. Edgar	0
3	Decline in the Incidence of Distant Recurrence of Breast Cancer: A Population-Based Health Record Linkage Study, Australia 2001–2016 2023 ·Cancer Epidemiology Biomarkers & Prevention ·Sarah J. Lord, Benjamin Daniels, Dianne L. O’Connell, Belinda E. Kiely, Jane Beith, Andrea L. Smith, Sallie‐Anne Pearson, (unknown), Max Bulsara, Nehmat Houssami	0
4	Hospitalizations and Cost of Inpatient Care for Physical Diseases in Survivors of Childhood Cancer in Western Australia: A Longitudinal Matched Cohort Study 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Thomas Walwyn, Daniel White, Catherine S. Choong, Max Bulsara, David B. Preen, Jeneva L. Ohan	0
5	Long term risk of distant metastasis in women with non‐metastatic breast cancer and survival after metastasis detection: a population‐based linked health records study 2022 ·The Medical Journal of Australia ·Sarah J. Lord, Benjamin Daniels, Belinda E. Kiely, Dianne L. O’Connell, Jane Beith, Sallie‐Anne Pearson, (unknown), Max Bulsara, Nehmat Houssami	8
6	Effectiveness of nurse-led volunteer support and technology-driven pain assessment in improving the outcomes of hospitalised older adults: protocol for a cluster randomised controlled trial 2022 ·BMJ Open ·Rosemary Saunders, Kate Crookes, Karla Seaman, (unknown), Caroline Bulsara, Max Bulsara, Beverley Ewens, (unknown), (unknown), (unknown), (unknown), J. C. Hughes, Mustafa Atee, Kim‐Huong Nguyen, Bev OʼConnell, (unknown), Christopher Etherton‐Beer	2
7	Comparing an eHealth Program (My Hip Journey) With Standard Care for Total Hip Arthroplasty: Randomized Controlled Trial 2021 ·Australasian Journal of Paramedicine ·Rosemary Saunders, Karla Seaman, (unknown), Max Bulsara, (unknown), (unknown), (unknown), Beverley Ewens, Trudy Sullivan, (unknown), Lisa Whitehead	9
8	Prevalence of frailty and pain in hospitalised adult patients in an acute hospital: a protocol for a point prevalence observational study 2021 ·BMJ Open ·Rosemary Saunders, Kate Crookes, Mustafa Atee, Caroline Bulsara, Max Bulsara, Christopher Etherton‐Beer, Beverley Ewens, (unknown), (unknown), (unknown), (unknown), Kim‐Huong Nguyen, Bev OʼConnell, Karla Seaman, J. C. Hughes	3
9	Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase 2021 ·Research in Social and Administrative Pharmacy ·Karla Seaman, Max Bulsara, Frank Sanfilippo, Anna Kemp, Elizabeth E. Roughead, Caroline Bulsara, Gerald F. Watts, David B. Preen	2
10	Incidence of type 1 diabetes in 0 to 14 year olds in Australia from 2002 to 2017 2020 ·Pediatric Diabetes ·Aveni Haynes, Max Bulsara, Phil Bergman, Fergus Cameron, Jennifer Couper, Maria E. Craig, (unknown), Stephanie Johnson, Antony Lafferty, Angela Titmuss, Elizabeth A. Davis	20
11	A randomized controlled trial of WATAAP to promote physical activity in colorectal and endometrial cancer survivors 2019 ·Psycho-Oncology ·Chloé Maxwell‐Smith, Dana Hince, Paul A. Cohen, Max Bulsara, Terry Boyle, Cameron Platell, Patrick Tan, Michael D. Levitt, Paul Salama, Jason Tan, Stuart Salfinger, Gregory Makin, Ganendra Raj Mohan, Ruth Jiménez‐Castuera, Sarah J. Hardcastle	45
12	Cuffed endotracheal tubes in infants less than 3 kg: A retrospective cohort study 2018 ·Pediatric Anesthesia ·Rebecca Thomas, Shripada Rao, Corrado Minutillo, (unknown), Max Bulsara	27
13	Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer 2017 ·Public Health Research & Practice ·Derrick Lopez, Anna Kemp, Christobel Saunders, Elizabeth E. Roughead, Frances Boyle, Max Bulsara, David B. Preen	1
14	Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial 2017 ·Journal of Medical Imaging and Radiation Oncology ·(unknown), Martin A. Ebert, Annette Haworth, Allison Steigler, Angel Kennedy, Max Bulsara, Rachel Kearvell, David Joseph, James W. Denham	6
15	Quality of life and posttraumatic growth after adult burn: A prospective, longitudinal study 2017 ·Burns ·Lisa Martin, Michelle L. Byrnes, Max Bulsara, Sarah McGarry, Suzanne Rea, Fiona Wood	39
16	Cosmesis and breast-related quality of life outcomes following intra-operative radiotherapy for early breast cancer - a sub-study of the TARGIT - a trial 2016 ·UCL Discovery (University College London) ·Tammy Corica, Anna K. Nowak, (unknown), Max Bulsara, Mandy Taylor, Jayant S. Vaidya, Michael Baum, (unknown)	2
17	Early primary care physician contact and health service utilisation in a large sample of recently released ex-prisoners in Australia: prospective cohort study 2015 ·BMJ Open ·Jesse T Young, Diane Arnold‐Reed, David B. Preen, Max Bulsara, Nick Lennox, Stuart A. Kinner	37
18	OMITTING WHOLE BREAST RADIOTHERAPY DOES NOT INCREASE AXILLARY RECURRENCE - DATA FROM TARGIT-A TRIAL 2013 ·UCL Discovery (University College London) ·Jayant S. Vaidya, Max Bulsara, Frederik Wenz, Samuele Massarut, David Joseph, (unknown), (unknown), Michael Baum, (unknown)	1
19	Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus. 2010 ·SHILAP Revista de lepidopterología ·Silvia Lee, (unknown), James Flexman, Wendy Cheng, Mark Watson, Enrico Rossi, Leon A. Adams, Max Bulsara, Patricia Price	14
20	TARGIT (TARGETED INTRA-OPERATIVE RADIOTHERAPY FOR EARLY STAGE BREAST CANCER): RESULTS FROM THE TARGIT A RANDOMIZED CONTROLLED TRIAL 2010 ·UCL Discovery (University College London) ·M Baum, Jayant S. Vaidya, (unknown), Mohammed Keshtgar, NR Williams, (unknown), Max Bulsara, Christobel Saunders, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact